June R Eisenman from 2444 3Rd Ave W, Seattle, WA 98119, age 71

Us Patents

Polynucleotides Encoding Epithelium-Derived T-Cell Factor And Uses Thereof
view source
US Patent:

7192935, Mar 20, 2007
Filed:

Nov 28, 2000
Appl. No.:

09/724841
Inventors:

Kenneth H. Grabstein - Mercer Island WA, US
Dirk M. Anderson - Seattle WA, US
June R. Eisenman - Seattle WA, US
Victor Fung - Redmond WA, US
Charles Rauch - Bainbridge Island WA, US
Assignee:

Amgen Inc. - Thousand Oaks CA
International Classification:

A61K 48/00
C12N 15/24
US Classification:

514 44, 536 243, 536 2431
Abstract:

Nucleic acid sequences which encode biologically active ETF, expression vectors which direct the expression of ETF, ETF polypeptides, antibodies which specifically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.

Method Of Treating Cancer By Administering An Epithelum-Derived T-Cell Factor
view source
US Patent:

7625553, Dec 1, 2009
Filed:

Feb 9, 2007
Appl. No.:

11/704726
Inventors:

Kenneth H. Grabstein - Mercer Island WA, US
Dirk M. Anderson - Seattle WA, US
June R. Eisenman - Seattle WA, US
Victor Fung - Redmond WA, US
Charles Rauch - Bainbridge Island WA, US
Assignee:

Immunex Corporation - Seattle WA
International Classification:

A61K 38/19
A61K 38/20
US Classification:

424 852, 514 2, 514 8, 514 12
Abstract:

Nucleic acid sequences which encode biologically active ETF, expression vectors which direct the expression of ETF, ETF polypeptides, antibodies which specifically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.

Epithelium-Derived T-Cell Factor Antibodies
view source
US Patent:

58920013, Apr 6, 1999
Filed:

Oct 4, 1996
Appl. No.:

8/725969
Inventors:

Kenneth H. Grabstein - Mercer Island WA
Dirk M. Anderson - Seattle WA
June R. Eisenman - Seattle WA
Victor Fung - Redmond WA
Charles Rauch - Bainbridge Island WA
Assignee:

Immunex Corporation - Seattle WA
International Classification:

C07K 1624
US Classification:

5303879
Abstract:

Nucleic acid sequences which encode biologically active ETF, expression vectors which direct the expression of ETF, ETF polypeptides, antibodies which specifically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.

Epithelium-Derived T-Cell Factor
view source
US Patent:

55741380, Nov 12, 1996
Filed:

Feb 22, 1995
Appl. No.:

8/393305
Inventors:

Kenneth H. Grabstein - Mercer Island WA
Dirk M. Anderson - Seattle WA
June R. Eisenman - Seattle WA
Victor Fung - Redmond WA
Charles Rauch - Bainbridge Island WA
Assignee:

Immunex Corporation - Seattle WA
International Classification:

A61K 3820
C07K 1454
US Classification:

530351
Abstract:

Nucleic acid sequences which encode biologically active ETF, expression vectors which direct the expression of ETF, ETF polypeptides, antibodies which specifically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.

Antibodies To Epithelium-Derived T-Cell Factor
view source
US Patent:

61843598, Feb 6, 2001
Filed:

Nov 9, 1998
Appl. No.:

9/189193
Inventors:

Kenneth H. Grabstein - Mercer Island WA
Dirk M. Anderson - Seattle WA
June R. Eisenman - Seattle WA
Victor Fung - Redmond WA
Charles Rauch - Bainbridge Island WA
Assignee:

Immunex Corporation - Seattle WA
International Classification:

C07K 1624
A61K 39395
C12N 512
US Classification:

53038823
Abstract:

Nucleic acid sequences which encode biologically active ETF, expression vectors which direct the expression of ETF, ETF polypeptides, antibodies which specifically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.

Method For Treating Or Preventing Gastrointestinal Disease With Epithelium-Derived T-Cell Factor
view source
US Patent:

57076162, Jan 13, 1998
Filed:

Oct 4, 1996
Appl. No.:

8/726817
Inventors:

Kenneth H. Grabstein - Mercer Island WA
Dirk M. Anderson - Seattle WA
June R. Eisenman - Seattle WA
Victor Fung - Redmond WA
Charles Rauch - Bainbridge Island WA
Assignee:

Immunex Corporation - Seattle WA
International Classification:

A61K 3820
C12N 1524
C07K 1454
US Classification:

424 852
Abstract:

Nucleic acid sequences which encode biologically active ETF, expression vectors which direct the expression of ETF, ETF polypeptides, antibodies which specifically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.

Dna Encoding Epithelium-Derived T-Cell Factor
view source
US Patent:

55523030, Sep 3, 1996
Filed:

Mar 8, 1993
Appl. No.:

8/031399
Inventors:

Kenneth Grabstein - Mercer Island WA
Dirk Anderson - Seattle WA
June Eisenman - Seattle WA
Victor Fung - Redmond WA
Charles Rauch - Bainbridge Island WA
Assignee:

Immunex Corporation - Seattle WA
International Classification:

C12P 2106
C12N 1524
C12N 510
C07K 1454
US Classification:

435 6951
Abstract:

There is disclosed a mammalian epithelium-derived T-cell factor (EFT) polypeptide, derivatives thereof, DNA sequences, recombinant DNA molecules and transformed host cells that produce ETF polypeptides. More particularly, this invention provides isolated mammalian ETF polypeptides and derivatives thereof that regulate events in T-lymphocyte proliferation.

Method Of Treatment With Epithelium Derived T-Cell Factor
view source
US Patent:

59852623, Nov 16, 1999
Filed:

Feb 3, 1997
Appl. No.:

8/794524
Inventors:

Kenneth H. Grabstein - Mercer Island WA
Dirk M. Anderson - Seattle WA
June R. Eisenman - Seattle WA
Victor Fung - Redmond WA
Charles Rauch - Bainbridge Island WA
Assignee:

Immunex Corporation - Seattle WA
International Classification:

A61K 3820
C07K 1454
C12N 1524
US Classification:

424 852
Abstract:

Nucleic acid sequences which encode biologically active EMF, expression vectors which direct the expression of ETF, ETE polypeptides, antibodies which specffically bind ETF and processes for preparing the same are disclosed. Also disclosed are methods for treating or preventing gastrointestinal diseases and HIV or HIV-associated diseases.

Resumes

Scientist

view source

Location:

Seattle, WA

Industry:

Biotechnology

Work:

Resolve Therapeutics, Llc
Scientist
Icogenex Bioincubator
Consultant
Resolve Therapeutics Nov 2012 - Mar 2016
Consulting Scientist
Sustainable Path Foundation Apr 2002 - Dec 2013
Founder and Board Co-Chair
Amgen Jul 2002 - Oct 2007
Senior Scientist, Protein Chemistry

Education:

Washington State University
Master of Science, Masters Union College
Bachelors, Bachelor of Science Bard College at Simon's Rock

Skills:

Biotechnology
Molecular Biology
Lifesciences
Drug Discovery
Life Sciences
Biopharmaceuticals
Research
Immunology
Biochemistry
Grants
Nonprofits
Protein Chemistry
Fundraising
Strategic Planning
Monoclonal Antibodies
Bioinformatics
Philanthropy